Mereo reaches exclusive licensing deal with AstraZeneca 1 234 567

Mereo reaches exclusive licensing deal with AstraZeneca

livecharts.co.uk

Clinical stage biopharmaceutical company Mereo BioPharma Group has announced that it has reached an agreement with AstraZeneca for an exclusive license - including an option to acquire - the oral inhibitor of neutrophil elastase AZD9668.

Full news

Share:

More:

1 234 567

1 234 567

1 234 567

1 234 567

1 234 567

1 234 567